… Adult patients with reversible obstructive lung disease defined … and a positive bronchodilator
reversibility test (FEV 1 increase … vibrating mesh nebulizer performance were tested in vitro …

… would have been demonstrable if the patients had been tested also with salbutamol via a
nebulizer or pMDI, due to the known different efficacy of different inhaler devices containing …

… From 2015 onwards, reversibility was routinely tested in response to 2.5 mg nebulised
salbutamol. A positive response was defined as an increase in FEV 1 of at least 12% and 200 mL. …

… reversibility testing classifies the airway obstruction as reversible or irreversible and thereby
guides therapeutic … responded to the bronchodilator reversibility test in our sample and the …

… was performed, similar to the first one, 10-20 minutes after inhalation of salbutamol by
nebulizer (reversibility test). For the forced expiratory volume in first second (FEV1), the increase …

… The rapidly reversible nature of the disease permits more … to increase the period of treatment
with a nebuliser, rather than … being ≤ 10% in all tested cases 57. In spontaneously breathing…

… Table 1: Mean measured values (3 sf) for pre- and post-salbutamol for all four lung function
tests for both MDI (and spacer) and nebuliser, along with their respective change scores and …

… (5%) combined with salbutamol in the nebulizer cup. Sputum was then processed using the
… ), whereas those combining both positive reversibility test and positive bronchial challenge …

… of delivery by a nebulizer in patients with chronic … testing are rare. This study assessed the
effects of salbutamol administered by an MDI with spacer versus a nebulizer on BDR testing of …

… Reversibility of bronchoconstriction after inhalation of the drug can be used as an indicator
… One way analysis of variance (ANOVA) test was used to compare the results with the least …